Table 3.
Results of the Wilcoxon signed rank tests to evaluate changes in subjective experience after treatment compared to before (Δ).
| Domain | Test statistics S | p-value | Adjusted p-value |
|---|---|---|---|
| Fatigue | −880.50 | 0.0002 | 0.0003 |
| Headache | −604.50 | 0.0106 | 0.0114 |
| Tired eyes | −769.50 | 0.0005 | 0.0006 |
| Troubles focusing | −1208.00 | <0.0001 | <0.0001 |
| Increased salivation | −410.00 | 0.0256 | 0.0256 |
| Sweating | −1053.00 | <0.0001 | <0.0001 |
| Nauseous | −1365.00 | <0.0001 | <0.0001 |
| Brain fog | −1382.50 | <0.0001 | <0.0001 |
| Blurred vision | −737.50 | 0.0017 | 0.0020 |
| Perception of self-motion with eyes open | −1536.00 | <0.0001 | <0.0001 |
| Perception of self-motion with eyes closed | −1450.00 | <0.0001 | <0.0001 |
| Vertigo | −1221.00 | <0.0001 | <0.0001 |
| Orientation problems | −1050.50 | <0.0001 | <0.0001 |
| Stomach discomfort | −1381.00 | <0.0001 | <0.0001 |
Subjective experience was assessed in 14 domains by means of a VAS. Adjusted p-Values are calculated according to the Benjamini-Hochberg correction for multiple comparison.
Bold values were used to indicate significance.